You are here

Output from 2000

 For reprints select : contact


Prüst M, Meijer J, Westerink RHS. The plastic brain: neurotoxicity of micro- and nanoplastics. Part Fibre Toxicol. 17, 24 (2020).

Lupu D, Andersson P, Bornehag CG, Demeneix B, Fritsche E, Gennings C, Lichtensteiger W, Leist M, Leonards PEG, Ponsonby AL, Scholze M, Testa G, Tresguerres JAF, Westerink RHS, Zalc B, Rüegg J. The ENDpoiNTs project: Novel testing strategies for endocrine disruptors linked to developmental neurotoxicity. Int J Mol Sci. 21, 3978 (2020).

Zwartsen A, Hondebrink L, de Lange DW, Westerink RHS. Hyperthermia exacerbates the acute effects of psychoactive substances on neuronal activity measured using microelectrode arrays (MEAs) in rat primary cortical cultures in vitro. Toxicol Appl Pharmacol. 397, 115015 (2020).

Tukker AM, Bouwman LMS, van Kleef RGDM, Hendriks HS, Legler J, Westerink RHS. Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) acutely affect human α1β2γ2L GABAA receptor and spontaneous neuronal network function in vitro. Sci Rep. 10, 5311 (2020).

Liu F, Westerink RHS. Neurotoxicity of drug of abuse. Neurotoxicology 78, 161-162 (2020).

Zwartsen A, Olijhoek ME, Westerink RHS, Hondebrink L. Hazard characterization of synthetic cathinones using viability, monoamine reuptake, and neuronal activity assays. Front Neurosci. 14, 9 (2020).

Post Y, Puschhof J, Beumer J, Kerkkamp HM, de Bakker MAG, Slagboom J, de Barbanson B, Wevers NR, Spijkers XM, Olivier T, Kazandjian TD, Ainsworth S, Iglesias CL, van de Wetering WJ, Heinz MC, van Ineveld RL, van Kleef RGDM, Begthel H, Korving J, Bar-Ephraim YE, Getreuer W, Rios AC, Westerink RHS, Snippert HJG, van Oudenaarden A, Peters PJ, Vonk FJ, Kool J, Richardson MK, Casewell NR, Clevers H. Snake venom gland organoids. Cell 180, 233-247.e21 (2020).

Tukker AM, Van Kleef RGDM, Wijnolts FMJ, De Groot A, Westerink RHS. Towards animal-free neurotoxicity screening: Applicability of hiPSC-derived neuronal models for in vitro seizure liability assessment. ALTEX 37, 121-135 (2020).

Zwartsen A, de Korte T, Nacken P, de Lange DW, Westerink RHS, Hondebrink L. Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings. Journal of Molecular and Cellular Cardiology 136,102-112 (2019).

Richardson JR, Fitsanakis V, Westerink RHS, Kanthasamy AG. Neurotoxicity of pesticides. Acta Neuropathologica 138, 343-362 (2019).

Zwartsen A, Hondebrink L, Westerink RHS. Changes in neuronal activity in rat primary cortical cultures induced by illicit drugs and new psychoactive substances (NPS) following prolonged exposure and washout to mimic human exposure scenarios. Neurotoxicology 74, 28-39 (2019).

Zwartsen A, Litjens CH, Hondebrink L, van den Heuvel JJ, Greupink R, Russel FG, de Lange DW, Legler J, Koenderink JB, Westerink RHS. Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT). Toxicology 422, 69-75 (2019).

Tukker AM, Wijnolts FMJ, de Groot A, Wubbolts RW, Westerink RHS. In vitro techniques for assessing neurotoxicity using human iPSC-derived neuronal models. NeuroMethods 145, 17-35 (2019).

Westerink RHS, van Thriel C, Levin ED, Shafer TJ. From molecular mechanisms to functional impact: Developing integrated analyses in neurotoxicology - The 16th biennial meeting International Neurotoxicology Association and 8th meeting of the NeuroToxicity Society. NeuroToxicology 72, 125-126 (2019).

Dusza HM, Cenijn PH, Kamstra JH, Westerink RHS, Leonards PEG, Hamers T. Effects of environmental pollutants on calcium release and uptake by rat cortical microsomes. NeuroToxicology 69, 266-277 (2018).

Tukker AM, Wijnolts FMJ, de Groot A, Westerink RHS. Human iPSC-derived neuronal models for in vitro neurotoxicity assessment. NeuroToxicology 67, 215-225 (2018).

Bal-Price A, Hogberg HT, Crofton KM, Daneshian M, FitzGerald RE, Fritsche E, Heinonen T, Hougaard Bennekou S, Klima S, Piersma AH, Sachana M, Shafer TJ, Terron A, Monnet-Tschudi F, Viviani B, Waldmann T, Westerink RHS, Wilks MF, Witters H, Zurich MG, Leist M. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicityALTEX 35, 306-352 (2018).

Zwartsen A, Hondebrink L, Westerink RHS. Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA). NeuroToxicology 66, 87-97 (2018).

Hondebrink L, Zwartsen A, Westerink RHS. Effect Fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacology & Therapeutics 182, 193-224 (2018).

Heusinkveld HJ, Westerink RHS. Comparison of different in vitro models for the assessment of pesticide-induced dopaminergic neurotoxicity. Toxicology in Vitro 45, 81-88 (2017).

Zwartsen A, Verboven AHA, van Kleef RGDM, Wijnolts FMJ, Westerink RHS, Hondebrink L. Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay. Toxicology In Vitro 45, 60-71 (2017).

Hondebrink L, Kasteel EEJ, Tukker AM, Wijnolts FMJ, Verboven AHA, Westerink RHS. Neuropharmacological characterization of the new psychoactive substance methoxetamine. Neuropharmacology 123, 1-9 (2017).

Van Thriel C, Levin E, Lein P, Costa LG, Westerink RHS. Neural mechanisms of functional impairment across the lifespan: The 15th Biennial Meeting of the International Neurotoxicology Association and 39th Annual Meeting of the Neurobehavioral Teratology Society. Neurotoxicology 59, 131-132 (2017).

Duarte DJ, Rutten JM, van den Berg M, Westerink RHS. In vitro neurotoxic hazard characterization of different tricresyl phosphate (TCP) isomers and mixtures. Neurotoxicology 59, 222-230 (2017).

Kasteel EE, Westerink RHS. Comparison of the acute inhibitory effects of Tetrodotoxin (TTX) in rat and human neuronal networks for risk assessment purposes. Toxicology Letters 270, 12-16 (2017).

Aschner M, Ceccatelli S, Daneshian M, Fritsche E, Hasiwa N, Hartung T, Hogberg HT, Leist M, Li A, Mundi WR, Padilla S, Piersma AH, Bal-Price A, Seiler A, Westerink RHS, Zimmer B, Lein P. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. ALTEX 34, 49-74 (2017).

Dingemans MM, Schütte MG, Wiersma DM, de Groot A, van Kleef RG, Wijnolts FM, Westerink RHS. Chronic 14-day exposure to insecticides or methylmercury modulates neuronal activity in primary rat cortical cultures. Neurotoxicology 57, 194-202 (2016).

Heusinkveld HJ, Wahle T, Campbell A, Westerink RHS, Tran L, Johnston H, Stone V, Cassee FR, Schins RP. Neurodegenerative and neurological disorders by small inhaled particles. Neurotoxicology 56, 94-106 (2016).

Meulenberg CJ, de Groot A, Westerink RHS, Vijverberg HPM. Organic solvent-induced changes in membrane geometry in human SH-SY5Y neuroblastoma cells - a common narcotic effect? Neurotoxicology 55, 74-82 (2016).

Heusinkveld HJ, van Vliet AC, Nijssen PC, Westerink RHS. In vitro neurotoxic hazard characterisation of dinitrophenolic herbicides. Toxicology Letters 252, 62-69 (2016).

Hondebrink L, Verboven AH, Drega WS, Schmeink S, de Groot MW, van Kleef RG, Wijnolts FM, de Groot A, Meulenbelt J, Westerink RHS. Neurotoxicity screening of (illicit) drugs using novel methods for analysis of microelectrode array (MEA) recordings. Neurotoxicology 55, 1-9 (2016).

Tukker AM, de Groot MW, Wijnolts FM, Kasteel EE, Hondebrink L, Westerink RH. Is the time right for in vitro neurotoxicity testing using human iPSC-derived neurons? ALTEX 33, 261-271 (2016).

de Groot MWGDM, van Kleef RGDM, de Groot A, Westerink RHS. In vitro developmental neurotoxicity following chronic exposure to 50 Hz extremely low frequency electromagnetic fields (ELF-EMF) in primary rat cortical cultures. Toxicological Sciences 149, 433-440 (2016).

Eubig PA, Westerink RHS. Introduction to special issue: Neurotoxicity of brominated and the quest for safer alternatives. Neurotoxicology and Teratology 52, 118 (2015).

Hendriks HS, and Westerink RHS. Neurotoxicity and risk assessment of brominated and alternative flame retardants. Neurotoxicology and Teratology 52, 248-269 (2015).

Hendriks HS, Koolen LA, Dingemans MML, Viberg H, Lee I, Leonards PE, Ramakers GE, Westerink RHS. Effects of neonatal exposure to the flame retardant tetrabromobisphenol-A, aluminium diethylphosphinate or zinc stannate on long-term potentiation and synaptic protein levels in mice. Archives of Toxicology 89, 2345-2354 (2015).

Hondebrink L, Hermans EJ, Schmeink S, van Kleef RGDM, Meulenbelt J, and Westerink RHS. Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: a novel mode of action. Neurotoxicology 51, 1-9 (2015).

Meijer M, Brandsema JA, Nieuwenhuis D, Wijnolts FMJ, Dingemans MML, and Westerink RHS. Inhibition of voltage-gated calcium channels after subchronic and repeated exposure of PC12 cells to different classes of insecticides. Toxicological Sciences 147, 607-617 (2015).

Heusinkveld HJ, van den Berg M, and Westerink RHS. In vitro dopaminergic neurotoxicity of pesticides: a link with neurodegeneration? Veterinary Quarterly 34, 120-131 (2014).

Nicolas J, Hendriksen PJ, van Kleef RGDM, de Groot A, Bovee TF, Rietjens IM, Westerink RHS. Detection of marine neurotoxins in food safety testing using a multielectrode array. Molecular Nutrition and Food Research 58, 2369-2378 (2014).

de Ree H, van den Berg M, Brand T, Mulder GJ, Simons R, Veldhuijzen van Zanten B, Westerink RHS. Reply ot Letter to the editor. Neurotoxicology 46, 167-168 (2015).

de Ree H, van den Berg M, Brand T, Mulder GJ, Simons R, Veldhuijzen van Zanten B, Westerink RHS. Health risk assessment of exposure to TriCresyl Phosphates (TCPs) in aircraft: A commentary. Neurotoxicology 45, 209-215 (2014).

Meijer M, Hendriks HS, Heusinkveld HJ, Langeveld WT, Westerink RHS. Comparison of plate reader-based methods with fluorescence microscopy for measurements of intracellular calcium levels for the assessment of in vitro neurotoxicity. Neurotoxicology 45, 31-37 (2014).

de Groot MWGDM, Westerink RHS. Assessment of the neurotoxic potential of exposure to 50 Hz extremely low frequency electromagnetic fields (ELF-EMF) in naïve and chemically stressed PC12 cells. Neurotoxicology 44, 358-364 (2014).

Westerink RHS. Reply on 'Prerequisites for a reliable introduction of in vitro neurotoxicity testing within the REACH framework'. Neurotoxicology 44, 366 (2014).

Meijer M, Dingemans MML, van den Berg M, Westerink RHS. Inhibition of voltage-gated calcium channels as common mode of action for (mixtures of) distinct classes of insecticides. Toxicological Sciences 141, 103-111 (2014).

Litjens R, Brunt T, Alderliefste G-J, Westerink RHS. Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases. European Neuropsychopharmacology 24, 1309-1322 (2014).

de Groot DM, Westerink RHS, Lammers JH, Fox DA, van Thriel C, Llorens J. Neurodevelopmental basis of health and disease: The 14th meeting of the International Neurotoxicology Association. Neurotoxicology 43, 143-159 (2014).

Llorens J, van Thriel C, Fox DA, Lammers J, Westerink RHS, de Groot DM. Neurodevelopmental basis of health and disease: The 14th meeting of the International Neurotoxicology Association. Neurotoxicology 43, 1-2 (2014).

Meijer M, Hamers T, Westerink RHS. Acute disturbance of calcium homeostasis in PC12 cells as a novel mechanism of action for (sub)micromolar concentrations of organophosphate insecticides. Neurotoxicology 43, 110-116 (2014).

de Groot MWGDM, Westerink RHS. Chemically-induced oxidative stress increases the vulnerability of PC12 cells to rotenone-induced toxicity. Neurotoxicology 43, 102-109 (2014).

Gassmann K, Schreiber T, Dingemans MML, Krause G, Roderigo C, Giersiefer S, Schuwald J, Moors M, Unfried K, Bergman A, Westerink RHS, Rose CR, Fritsche E. BDE-47 and 6-OH-BDE-47 modulate calcium homeostasis in primary fetal human neural progenitor cells via ryanodine receptor-independent mechanisms. Archives of Toxicology 88, 1537-1548 (2014).

Hendriks HS, Meijer M, Muilwijk M, van den Berg M, Westerink RHS. A comparison of the in vitro cyto- and neurotoxicity of brominated and halogen-free flame retardants: Prioritization in search for safe(r) alternatives. Archives of Toxicology 88, 857-869 (2014).

De Groot MWGDM, Dingemans MML, Rus KH, de Groot A, Westerink RHS. Characterization of calcium responses and electrical activity in differentiating mouse neural progenitor cells in vitro. Toxicological Sciences 137, 428-435 (2014).

Westerink RHS. Modulation of cell viability, oxidative stress, calcium homeostasis, and voltage- and ligand-gated ion channels as common mechanisms of action of (mixtures of) non-dioxin-like polychlorinated biphenyls and polybrominated diphenyl ethers. Envrionmental Science and Pollution Research 21, 6373-6383 (2014).

Westerink RHS. Do we really want to REACH out to in vitro. Neurotoxicology 39, 169-172 (2013).

Rijnierse A, Kraneveld AD, Salemi A, Zwaneveld S, Goumans AP, Rychter JW, Thio M, Redegeld FA, Westerink RHS, Kroese ABA. Immunoglobulinfree light chains reduce in an antigen-specific manner the rate of rise of action potentials of mouse non-nociceptive dorsal root ganglion neurons. Journal of Neuroimmunology 264, 14-23 (2013).

Solak KA, Wijnolts FM, Pralong FP, Blaauboer BJ, van den Berg M, Westerink RHS, van Duursen MB. In vitro neuroendocrine effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the AhR-expressing hypothalamic rat GnV-3 cell line. Toxicology 311, 124-134 (2013).

Heusinkveld HJ, Molendijk J, van den Berg M, and Westerink RHS. Azole fungicides disturb intracellular Ca2+ in an additive manner in dopaminergic PC12 cells. Toxicological Sciences 134, 374-381 (2013).

Hondebrink L, Tan S, Hermans E, van Kleef RGDM, Meulenbelt J and Westerink RHS. Additive inhibition of α1β2y2 GABAA receptors by mixtures of commonly used drugs of abuse. Neurotoxicology 35, 23-29 (2013).

de Groot MWGDM, Westerink RHS and Dingemans MML. Don´t judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing. Toxicological Sciences 132, 1-7 (2013).

Waaijers SL, Kong D, Hendriks HS, de Wit CA, Cousins IT, Westerink RHS, Leonards PE, Kraak MH, Admiraal W, de Voogt P and Parsons JR. Persistence, bioaccumulation, and toxicity of halogen-free flame retardants. Reviews of Environmental Contamination and toxicology 222, 1-71 (2013).

Rietjens SJ, Hondebrink L, Westerink RHS and Meulenbelt J. Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions. Critical Reviews in Toxicology 42, 854-876 (2012).

Vijverberg HPM and Westerink RHS. Sense in Pb2+ sensing. Toxicological Sciences 130, 1-3 (2012).

Hendriks HS, van Kleef RGDM and Westerink RHS. Modulation of human α4β2 nicotinic acetylcholine receptors by brominated and halogen-free flame retardants as a measure for in vitro neurotoxicity. Toxicology Letters 213, 266-274 (2012).

Hendriks HS, van Kleef RGDM, van den Berg M and Westerink RHS. Multiple novel modes of action involved in the in vitro neurotoxic effects of tetrabromobisphenol-A (TBBPA). Toxicological Sciences 128, 235-246 (2012).

Westerink RHS, Beekwilder JP and Wadman WJ. Differential alterations of synaptic plasticity in dentate gyrus and CA1 hippocampal area of Calbindin-D28K knockout mice. Brain Research 1450, 1-10 (2012).

Langeveld WT, Meijer M and Westerink RHS. Differential effects of 20 non-dioxin-like PCBs on basal and depolarisation-evoked intracellular calcium levels in PC12 cells. Toxicological Sciences 126, 487-496 (2012).

Heusinkveld HJ and Westerink RHS. The organochlorine insecticides lindane, dieldrin and their binary mixture disturb calcium homeostasis in dopaminergic PC12 cells. Environmental Science & Technology 46, 1842-1848 (2012).

van Thriel C, Westerink RHS, Beste C, Bale AS, Lein PJ and Leist M. Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. Neurotoxicology 33, 911-924 (2012).

Hondebrink L, Meulenbelt J, Rietjens SJ, Meijer M and Westerink RHS. Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.  Neurotoxicology 33, 255-260 (2012).

Stenberg M, Hamers T, Machala M, Fonnum F, Stenius U, Lauy AA, van Duursen MB, Westerink RHS, Antunes Fernandes EC and Andersson PL. Multivariate toxicity profiles and QSAR modeling of non-dioxin-like PCBs - An investigation of in vitro screening data from ultra-pure congeners. Chemosphere 85, 1423-1429 (2011).

Hondebrink L, Meulenbelt J, van Kleef, RGDM, van den Berg M and Westerink RHS. Modulation of human GABAA receptor function: A novel mode of action of drugs of abuse. Neurotoxicology 32, 823-827 (2011).

Heusinkveld HJ and Westerink RHS. Caveats and limitations of plate reader-based high throughput kinetic measurements of intracellular calcium levels. Toxicology and Applied Pharmacology 255, 1-8 (2011).

Bagyánszki M, Torfs P, Krecsmarik M, Fekete E, Adriaensen D, Van Nassauw L, Timmermans JP and Kroese ABA. Chronic alcohol consumption induces an overproduction of NO by nNOS- and iNOS-expressing myenteric neurons in the murine small intestine. Neurogastroenterology and Motility 23, e237-248 (2011).

Dingemans MML, van den Berg M and Westerink RHS. Neurotoxicity of brominated flame retardants: (in-)direct effects of parent and hydroxylated polybrominated diphenyl ethers on the (developing) nervous system. Environmental Health Perspectives 119, 900-907 (2011).

Dingemans MML, van den Berg M and Westerink RHS. Neurotoxicity of PBDEs: Dingemans et al. respond. Environmental Health Perspectives 119, a331-a332 (2011).

Hondebrink L, Meulenbelt J, Meijer M, van den Berg M and Westerink RHS. High concentrations of MDMA (‘ecstasy’) and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells. Neuropharmacology 61, 202-208 (2011).

van Kempen GTH, vanderLeest HT, van den Berg RJ, Eilers P and Westerink RHS. Three distinct modes of exocytosis revealed by amperometry in neuroendocrine cells. Biophysical Journal 100, 968-977 (2011).

Rychter JW, Van Nassauw L, Timmermans JP, Akkermans LMA, Westerink RHS and Kroese ABA. CGRP1 receptor activation induces piecemeal release of protease-1 from mouse bone marrow-derived mucosal mast cells. Neurogastroenterology and Motility 23, e57-68 (2011).

Adams KL, Maxson MM, Mellander L, Westerink RHS and Ewing AG. Estradiol inhibits depolarization-evoked exocytosis in PC12 cells via N-type voltage-gated calcium channels. Cellular and Molecular Neurobiology 30, 1235-1242 (2010).

Antunes Fernandes EC, Hendriks HS, van Kleef RGDM, Reniers A, Andersson PL, van den Berg M and Westerink RHS. Activation and potentiation of human GABAA receptors by non-dioxin-like-PCBs depends on chlorination pattern. Toxicological Sciences 118, 183-190 (2010).

Antunes Fernandes EC, Hendriks HS, van Kleef RGDM, van den Berg M and Westerink RHS. Potentiation of the human GABAA receptor as a novel mode of action of lower-chlorinated non-dioxin-like PCBs. Environmental Science & Technology 44, 2864-2869 (2010).

Dingemans MML, Heusinkveld HJ, van den Berg M, Bergman Å and Westerink RHS. Bromination pattern of hydroxylated metabolites of BDE-47 affects their potency to release calcium from intracellular stores in PC12 cells. Environmental Health Perspectives 118, 519-525 (2010).

Dingemans MML, van den Berg M, Bergman Å and Westerink RHS. Calcium-related processes involved in the inhibition of depolarization-evoked calcium increase by hydroxylated PBDEs in PC12 cells. Toxicological Sciences 114, 302-309 (2010).

Hendriks HS, Antunes Fernandes EC, Bergman Å, van den Berg M and Westerink RHS. PCB-47, PBDE-47, and 6-OH-PBDE-47 differentially modulate human GABAA and α4ß2 nicotinic acetylcholine receptors. Toxicological Sciences 118, 635-642 (2010).

Heusinkveld HJ, Thomas GO, Lamot I, van den Berg M, Kroese ABA and Westerink RHS. Dual actions of lindane (γ-hexachlorocyclohexane) on calcium homeostasis and exocytosis in rat PC12 cells. Toxicology and Applied Pharmacology 248, 12-19 (2010).

Rychter JW, van Nassauw L, Brown JK, van Marck E, Knight PA, Miller HR, Kroese ABA and Timmermans JP. Impairment of intestinal barrier and secretory function as well as egg excretion during intestinal schistosomiasis occur independently of mouse mast cell protease-1. Parasite Immunology 32, 221-231 (2010).

Westerink RHS and Hondebrink L. Are high-throughput measurements of intracellular calcium using plate-readers sufficiently accurate and reliable? Toxicology and Applied Pharmacology 249, 247-248 (2010).

Dingemans MML, Heusinkveld HJ, de Groot A, Bergman Å, van den Berg M and Westerink RHS. Hexabromocyclododecane inhibits depolarization-induced increase in intracellular calcium levels and neurotransmitter release in PC12 cells. Toxicology Sciences 107, 490-497 (2009).

Hondebrink L, Meulenbelt J, Timmerman JG, van den Berg M and Westerink RHS. Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure. Journal of Neurochemistry 111, 624-633 (2009).

Rychter JW, van Minnen LP, Verheem A, Timmerman HM, Rijkers GT, Schipper ME, Gooszen HG, Akkermans LM and Kroese ABA. Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis. Surgery 145, 157-167 (2009).

Bal-Price AK, Sunol C, Weiss DG, van Vliet E, Westerink RHS and Costa LG. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs. Neurotoxicology 29, 520-531 (2008).

Dingemans MML, de Groot A, van Kleef RGDM, Bergman Å, van den Berg M, Vijverberg HPM and Westerink RHS. Hydroxylation increases the neurotoxic potential of BDE-47 to affect exocytosis and calcium homeostasis in PC12 cells. Environmental Health Perspectives 116, 637-643 (2008).

van Kleef RGDM, Vijverberg HPM and Westerink RHS. Selective inhibition of human heteromeric α9α10 nicotinic acetylcholine receptors at a low agonist concentration by low concentrations of ototoxic organic solvents. Toxicology In Vitro 22, 1568-1572 (2008).

Westerink RHS and Ewing AG. The PC12 cell as model for neurosecretion. Acta Physiologica (Oxford, England) 192, 273-85 (2008).

Dingemans MML, Ramakers GM, Gardoni F, van Kleef RGDM, Bergman Å, Di Luca M, van den Berg M, Westerink RHS and Vijverberg HPM. Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus. Environmental Health Perspectives 115, 865-870 (2007).

Westerink RHS. Targeting exocytosis: ins and outs of the modulation of quantal dopamine release. CNS & Neurological Disorders Drug Targets 5, 57-77 (2006).

Westerink RHS, Rook MB, Beekwilder JP and Wadman WJ. Dual role of calbindin-D28K in vesicular catecholamine release from mouse chromaffin cells. Journal of Neurochemistry 99, 628-640 (2006).

Smulders CJ, Zwart R, Bermudez I, van Kleef RGDM, Groot-Kormelink PJ and Vijverberg HPM. Cholinergic drugs potentiate human nicotinic α4ß2 acetylcholine receptors by a competitive mechanism. European Journal of Pharmacology 509, 97-108 (2005).

Smulders CJ, Bueters TJ, Vailati S, van Kleef RGDM and Vijverberg HPM. Block of neuronal nicotinic acetylcholine receptors by organophosphate insecticides. Toxicological Sciences 82, 545-554 (2004).

Smulders CJ, Van Kleef RGDM, de Groot A, Gotti C and Vijverberg HPM. A noncompetitive, sequential mechanism for inhibition of rat α4ß2 neuronal nicotinic acetylcholine receptors by carbamate pesticides. Toxicological Sciences 82, 219-227 (2004).

Westerink RHS. Exocytosis: using amperometry to study presynaptic mechanisms of neurotoxicity. Neurotoxicology 25, 461-470 (2004).

Westerink RHS. Modulation of exocytosis by exogenous and endogenous factors. in: Cell Biology of the Chromaffin Cell.(eds Borges, R. & Gandia, L.) 9-21 (2004).

Westerink RHS and Vijverberg HPM. Modulation of Ca2+-independent, Pb2+-induced exocytosis from rat PC12 cells by CaMK II. in: Cell Biology of the Chromaffin Cell (eds Borges, R. & Gandia, L.) 47-54 (2004).

Carbonnelle E, Sparatore F, Canu-Boido C, Salvagno C, Baldani-Guerra B, Terstappen G, Zwart R, Vijverberg HPM, Clementi F and Gotti C. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes. European Journal of Pharmacology 471, 85-96 (2003).

Meulenberg, CJ and Vijverberg HPM. Selective inhibition of gamma-aminobutyric acid type A receptors in human IMR-32 cells by low concentrations of toluene. Toxicology 190, 243-248 (2003).

Meulenberg CJ, Wijnker AG and Vijverberg HPM. Relationship between olive oil:air, saline:air, and rat brain:air partition coefficients of organic solvents in vitro. Journal of Toxicology and Environmental Health 66, 1985-1998 (2003).

Smulders CJ, Bueters TJ, Van Kleef RGDM and Vijverberg HPM. Selective effects of carbamate pesticides on rat neuronal nicotinic acetylcholine receptors and rat brain acetylcholinesterase. Toxicology and Applied Pharmacology 193, 139-146 (2003).

Westerink RHS, Klompmakers AA, Westenberg HG and Vijverberg HPM. Signaling pathways involved in Ca2+- and Pb2+-induced vesicular catecholamine release from rat PC12 cells. Brain Research 957, 25-36 (2002).

Westerink RHS and Vijverberg HPM. Vesicular catecholamine release from rat PC12 cells on acute and subchronic exposure to polychlorinated biphenyls. Toxicology and Applied Pharmacology 183, 153-159 (2002).

Westerink RHS and Vijverberg HPM. Toluene-induced, Ca2+-dependent vesicular catecholamine release in rat PC12 cells. Neuroscience Letters 326, 81-84 (2002).

Westerink RHS and Vijverberg HPM Ca2+ -independent vesicular catecholamine release in PC12 cells by nanomolar concentrations of Pb2+. Journal of Neurochemistry 80, 861-873 (2002).

Meulenberg CJ and Vijverberg HPM. Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds. Toxicology and Applied Pharmacology 165, 206-216 (2000).

van Hooft JA and Vijverberg HPM. 5-HT3 receptors and neurotransmitter release in the CNS: a nerve ending story? Trends in Neurosciences 23, 605-610 (2000).

Westerink RHS, de Groot A and Vijverberg HPM. Heterogeneity of catecholamine-containing vesicles in PC12 cells. Biochemical and Biophysical Research Communications 270, 625-630 (2000).

Zwart R, van Kleef RGDM, Gotti C, Smulders CJ and Vijverberg HPM. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs. Journal of Neurochemistry 75, 2492-2500 (2000).

Zwart R and Vijverberg HPM. Potentiation and inhibition of neuronal α4ß4 nicotinic acetylcholine receptors by choline. European Journal of Pharmacology 393, 209-214 (2000).